In the majority of studies, Sesn2 primarily plays an inhibitory role in cancer, but it has also been reported that Sesn2 promotes the development of cancer [32], such as pancreatic cancer [33], liver cancer [34], and melanoma [35]. This evidence concerns the gene SESN2 and pancreatic neoplasm.